Biogen LUNSUMIO — After Second GAZYVA Threshold Date remained flat by 0.0% to 35.0% in Q1 2026 compared to the prior quarter.
Passing this date signals the commencement of a new phase in the collaboration, often involving adjusted profit-sharing or cost-allocation rules.
This metric identifies the temporal milestone occurring after a secondary performance threshold related to the Gazyva pr...
Common in multi-product collaboration agreements where milestones in one product affect the terms of another.
biib_segment_lunsumio_after_second_gazyva_threshold_date| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | 35% | 35% | 35% | 35% |
| QoQ Change | — | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +0.0% |